TimothyCFaganMD

PubMed

• 15 citations
  Levodopa Positively Affects Neovascular Age-Related Macular Degeneration.
  Anna G. Figueroa, Brennan M. Boyd, Cory A. Christensen, Cameron G. Javid, Brian S. McKay, Timothy C. Fagan, Robert W. Snyder> ;The American Journal of Medicine. 2021 Jan 1
• Payments to Physicians, Prescribing Rates, and More Appropriate Conclusions
  Timothy C. Fagan> ;JAMA Internal Medicine. 2016 Oct 1
• 5 citations
  Pulse pressure responses in patients treated with Valsartan and hydrochlorothiazide combination therapy.
  Renzo Carretta, Peter Trenkwalder, F. Martinez, Andrzej Tykarski, I. Teitelbaum, Timothy C. Fagan, Pascale Oddou, J.-M. Mallion> ;The Journal of International Medical Research. 2003 Oct 1
• 53 citations
  Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy.
  Jean-Michel Mallion, Renzo Carretta, Peter Trenkwalder, Jean-Felipe Martinez, Andrzej Tykarski, Ivor Teitelbaum, Pascale Oddou, Timothy C. Fagan> ;Blood Pressure. Supplement. 2003 May 1
• 24 citations
  A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes
  George L. Bakris, D.A. Sica, Venkata Ram, Timothy C. Fagan, Paul T. Vaitkus, Robert J. Anders> ;American Journal of Hypertension. 2002 Jan 1
• 22 citations
  Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitrates
  Timothy C. Fagan, Susan M. Buttler, Thomas Marbury, Addison A. Taylor, Anthony Edmonds> ;The American Journal of Cardiology. 2001 Oct 1
• 47 citations
  Effects of candesartan cilexetil in patients with severe systemic hypertension
  M.C. Reif, William B. White, Timothy C. Fagan, Suzanne Oparil, Terry L. Flanagan, Dianne T. Edwards, Daniel J. Cushing, Eric L. Michelson> ;The American Journal of Cardiology. 1998 Oct 15
• 51 citations
  Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy.
  Timothy C. Fagan, James R. Sowers> ;Archives of Internal Medicine. 1999 May 24
• 1 citations
  Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators.
  M Reif, W B White, T C Fagan, S Oparil, T L Flanagan, D T Edwards, D J Cushing, E L Michelson> ;The American Journal of Cardiology. 1998 Oct 15
• 85 citations
  The cardiovascular dysmetabolic syndrome
  Timothy C. Fagan, Prakash Deedwania> ;The American Journal of Medicine. 1998 Jul 6
• 5 citations
  Evolution of the Joint National Committee reports, 1988-1997. Evolution of the science of treating hypertension.
  Timothy C. Fagan> ;Archives of Internal Medicine. 1997 Nov 24
• 2 citations
  Blood Pressure Reduction and Tolerability of Felodipine ER in Older and Younger Hypertensive Patients
  Timothy C. Fagan> ;Journal of the American Geriatrics Society. 1997 Jun 1
• 6 citations
  Calcium antagonists and mortality. Another case of the need for clinical judgment.
  Timothy C. Fagan> ;Archives of Internal Medicine. 1995 Nov 13
• 3 citations
  Treatment of Mild Hypertension with Low Once‐Daily Doses of a Sustained‐Release Capsule Formulation of Verapamil
  Pamela J. Davis, Timothy C. Fagan, Mary J. Topmiller, Jon H. Levine, Keith C. Ferdinand> ;Journal of Clinical Pharmacology. 1995 Jan 1
• 37 citations
  Remembering the lessons of basic pharmacology.
  Timothy C. Fagan> ;Archives of Internal Medicine. 1994 Jul 11
• 20 citations
  The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers.
  U K Walle, Timothy C. Fagan, MJ Topmiller, Edward C. Conradi, Thomas Walle> ;British Journal of Clinical Pharmacology. 1994 Jan 1
• 4 citations
  Sustained-release nicardipine in mild-to-moderate hypertension
  Timothy C. Fagan, Elizabeth D. Tyler, Martha A. Reitman, Susan Kenley, Michael A. Weber> ;Chest. 1993 Aug 1
• 61 citations
  Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents
  Joel M. Neutel, David H.G. Smith, C. Venkata S. Ram, Norman M Kaplan, Vasilios Papademetriou, Timothy C. Fagan, Martin Lefkowitz, M.Kazem Kazempour, Michael A. Weber> ;The American Journal of Medicine. 1993 Feb 1
• 3 citations
  Diltiazem: its place in the antihypertensive armamentarium.
  Timothy C. Fagan> ;Journal of Cardiovascular Pharmacology. 1991 Jan 1
• 59 citations
  Clinical Review of Histamine2 Receptor Antagonists
  Robert J. Lipsy, Brian Fennerty, Timothy C. Fagan> ;Archives of Internal Medicine. 1990 Apr 1
• 4 citations
  Relationship between age and the cardiovascular response to meals.
  Timothy C. Fagan, Kenneth A. Conrad, Paula V. Mayshar, Mary J. Mackie> ;Cardiovascular Drugs and Therapy. 1990 Mar 1
• 19 citations
  Acute Reduction of Blood Pressure in Asymptomatic Patients With Severe Hypertension: An Idea Whose Time Has Come—and Gone
  Timothy C. Fagan> ;Archives of Internal Medicine. 1989 Oct 1
• 6 citations
  Nicardipine and hydrochlorothiazide in essential hypertension
  Timothy C. Fagan, Ronald D. Brown, Harold W. Schnaper, Peter Smolens, Michael Montijo, Eric Michelson, Kenneth A. Conrad, Jan Lessem, Donna Freedman> ;Clinical Pharmacology and Therapeutics. 1989 Apr 1
• 88 citations
  Effects of ketorolac tromethamine on hemostasis in volunteers.
  Kenneth A. Conrad, Timothy C. Fagan, Mary J. Mackie, Paula V. Mayshar> ;Clinical Pharmacology and Therapeutics. 1988 May 1
• 2 citations
  The influence of hydrochlorothiazide and tripamide on serum and urinary amylase.
  Kenneth A. Conrad, Timothy C. Fagan, Jarid A. Simons> ;Journal of Clinical Pharmacology. 1988 May 1
• Join now to see all